RxDoctor Payments Data

Susan Kioko, NP

Adult Health · Rockville, MDNPI 1720491293

Payments from drug & device makers

$522in general payments, 2019–2025

Across 25 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$151
  • Pfizer$52
  • Novo Nordisk$39
  • Abbott$38
  • AstraZeneca$36
  • Astellas Pharma US Inc$34
  • plus $173 from 8 others

What the payments were for

  • Food & beverage$522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$522 in reported general payments places this provider in the 55th percentile of 542 adult health providers in Maryland.

See all adult health providers in Maryland

Medicare billing

Part B allowed, 2024
$114,457
Medicare patients
405
Services billed
2,586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron14$9,150
Atorvastatin Calcium100$1,695
SynthroidLevothyroxine Sodium13$1,140
Losartan Potassium62$1,065
Levothyroxine Sodium66$755
Metoprolol Succinate32$732
Rosuvastatin Calcium26$667
Pantoprazole Sodium24$655
Famotidine51$555
Amlodipine Besylate79$549
Chlorthalidone11$407
Omeprazole30$386
Lisinopril54$221
Metformin Hcl ErMetformin Hcl19$219
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$34$9,15014 claims
AbbVieSynthroid$151$1,14013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 542 adult health providers in Maryland.

Other adult health in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →